FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
177 products match “Recombi” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Advateantihemophilic factor (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3053 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2400 mg/15mL; Hyaluronidase (Human recombinant) 30000 mg/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-515 |
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-1000 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 1600 mg/10mL; Hyaluronidase (Human recombinant) 20000 mg/10mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-510 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit |
| Novo Nordisk |
| 0169-8200 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2240 mg/14mL; Hyaluronidase (Human recombinant) 28000 mg/14mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-514 |
|---|
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7050 |
|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 3520 mg/22mL; Hyaluronidase (Human recombinant) 44000 mg/22mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-522 |
|---|
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-2000 |
|---|
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-5000 |
|---|
| Jiviantihemophilic factor (recombinant) pegylated-aucl | — | Kit | Bayer HealthCare LLC | 0026-3946 |
|---|
| Pediarixdiphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b (recombinant) and inactivated poliovirus vaccine combined | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 25 [iU]/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | A-S Medication Solutions | 50090-7541 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8300 |
|---|
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7201 |
|---|
| Advateantihemophilic factor (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3054 |
|---|
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant | — | Kit | CSL Behring Lengnau AG | 69911-475 |
|---|
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant | — | Kit | CSL Behring Lengnau AG | 69911-474 |
|---|